Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2018 08:30 ET | Source: Dyadic International, Inc.

Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap Research

JUPITER, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...
September 07, 2018 11:18 ET | Source: Dyadic International, Inc.

Dyadic International Announces Research Collaboration with Sanofi-Aventis

JUPITER, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1...
August 09, 2018 16:00 ET | Source: Dyadic International, Inc.

Dyadic International Reports Second Quarter 2018 Financial Results and Extension of Stock Repurchase Program

JUPITER, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...
July 26, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018

JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1...
June 18, 2018 09:50 ET | Source: Dyadic International, Inc.

Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics

Results Highlighted in BioProcess International and the Global Bioprocessing and Bioanalytics Congress 2018 JUPITER, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc....
May 10, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International Reports First Quarter 2018 Financial Results

Three new research collaborationsPositive results in our initial glycoengineering modifications of C1 strainsAchieving high levels of productivity for therapeutic proteinsBoard approved a reverse...
April 25, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018

JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1...
March 27, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International Announces 2017 Year End Results and Recent Developments

$49.1 million of cash, cash equivalents and investment securities as of December 31, 2017Successfully executed two funded collaborations in 2017 and signed three new collaborations in 2018Early data...
March 15, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International Appoints Chief Accounting Officer

JUPITER, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), today announced that Chief Financial Officer Thomas L. Dubinski  will be on a medical leave of...
March 13, 2018 16:30 ET | Source: Dyadic International, Inc.

Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018

JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1...